Hydroxymethylation and its potential implication in DNA repair system: A review and future perspectives

Gene

Volumn 564, Issue 2, 2015, Pages 109-118

  Shukla, Ankita ^a   Sehgal, Manika ^a   Singh, Tiratha Raj ^a  

^a JAYPEE UNIVERSITY OF INFORMATION TECHNOLOGY   (India)

Author keywords

Cancer; Cardiovascular; DNA repair; Hydroxymethylation; Psychotic disorders; TET family

Indexed keywords

5 HYDROXYMETHYLCYTOSINE; 5 METHYLCYTOSINE; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 1; MESSENGER RNA; MICRORNA; PROTEIN; REPETITIVE DNA; SPACER DNA; TET PROTEIN; UNCLASSIFIED DRUG; 5-HYDROXYMETHYLCYTOSINE; CYTOSINE;

CARDIOVASCULAR DISEASE; DNA METHYLATION; DNA MODIFICATION; DNA REPAIR; GENETIC TRANSCRIPTION; HUMAN; HUNTINGTON CHOREA; HYDROXYMETHYLATION; NEOPLASM; OXIDATION; PARKINSON DISEASE; PRIORITY JOURNAL; PSYCHOSIS; REVIEW; SCHIZOPHRENIA; ANALOGS AND DERIVATIVES; ANIMAL; CHEMISTRY; DEGENERATIVE DISEASE; GENETICS; MENTAL DISEASE; METABOLISM;

5-METHYLCYTOSINE; ANIMALS; CYTOSINE; DNA REPAIR; HUMANS; MENTAL DISORDERS; NEOPLASMS; NEURODEGENERATIVE DISEASES;

EID: 84928209457     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2015.03.075     Document Type: Review

References (94)

1. Aure M.R., Leivonen S.K., Fleischer T., Zhu Q., et al. Individual and combined effects of DNA methylation and copy number alterations on miRNA expression in breast tumors. Genome Biol. 2013, 14(11):R126.
2. Barrick C.J., Roberts R.B., Rojas M., Rajamannan N.M., et al. Reduced EGFR causes abnormal valvular differentiation leading to calcific aortic stenosis and left ventricular hypertrophy in C57BL/6J but not 129S1/SvImJ mice. Am. J. Physiol. Heart Circ. Physiol. 2009, 297(1):H65-H75.
3. Bernstein B.E., Mikkelsen T.S., Xie X., Kamal M., et al. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 2006, 125:315-326.
4. Bert S.A., Robinson M.D., Strbenac D., Statham A.L., et al. Regional activation of the cancer genome by long-range epigenetic remodeling. Cancer Cell 2013, 23(1):9-22.
5. Bhutani N., Burns D.M., Blau H.M. DNA demethylation dynamics. Cell 2011, 146:866-872.
6. Cheng J., Guo S., Chen S., Mastriano S.J., et al. An extensive network of TET2-targeting MicroRNAs regulates malignant hematopoiesis. Cell Rep. 2013, 5:471-481.
7. Chopra P., Papale L.A., White A.T., Hatch A., et al. Array-based assay detects genome-wide 5-mC and 5-hmC in the brains of humans, non-human primates, and mice. BMC Genomics 2014, 15:131.
8. Chouliaras L., Mastroeni D., Delvaux E., Grover A., et al. Consistent decrease in global DNA methylation and hydroxymethylation in the hippocampus of Alzheimer's disease patients. Neurobiol. Aging 2013, 34:2091-2099.
9. Coppieters N., Dieriks B.V., Lill C., Faull R.L., et al. Global changes in DNA methylation and hydroxymethylation in Alzheimer's disease human brain. Neurobiol. Aging 2014, 35:1334-1344.
10. Croce C.M. Causes and consequences of microRNA dysregulation in cancer. Nat. Rev. Genet. 2009, 10:704-714.
11. Delatte B., Fuks F. TET proteins: on the frenetic hunt for new cytosine modifications. Brief. Funct. Genomics 2013, 12(3):191-204.
12. Derijck A., van der Heijden G., Giele M., Philippens M., et al. DNA double-strand break repair in parental chromatin of mouse zygotes, the first cell cycle as an origin of de novo mutation. Hum. Mol. Genet. 2008, 17:1922-1937.
13. Ding X.C., Weiler J., Grosshans H. Regulating the regulators: mechanisms controlling the maturation of microRNAs. Trends Biotechnol. 2009, 27:27-36.
14. Enerly E., Steinfeld I., Kleivi K., Leivonen S.K., et al. miRNA-mRNA integrated analysis reveals roles for miRNAs in primary breast tumors. PLoS One 2011, 6:e16915.
15. Esteller M. Non-coding RNAs in human disease. Nat. Rev. Genet. 2011, 12:861-874.
16. Fan G., Beard C., Chen R.Z., Csankovszki G., et al. DNA hypomethylation perturbs the function and survival of CNS neurons in postnatal animals. J. Neurosci. 2001, 21:788-797.
17. Feng J., Zhou Y., Campbell S.L., Le T., et al. Dnmt1 and Dnmt3a maintain DNA methylation and regulate synaptic function in adult forebrain neurons. Nat. Neurosci. 2010, 13:423-430.
18. Ficz G., Branco M.R., Seisenberger S., Santos F., et al. Dynamic regulation of 5-hydroxymethylcytosine in mouse ES cells and during differentiation. Nature 2011, 473(7347):398-402.
19. Gehring M., Reik W., Henikoff S. DNA demethylation by DNA repair. Trends Genet. 2009, 25:82-90.
20. Globisch D., Münzel M., Müller M., Michalakis S., et al. Tissue distribution of 5-hydroxymethylcytosine and search for active demethylation intermediates. PLoS One 2010, 5(12):e15367.
21. Globisch D., Munzel M., Muller M., Michalakis S., et al. Tissue distribution of 5-hydroxymethylcytosine and search for active demethylation intermediates. PLoS One 2011, 5:e15367.
22. Grayson Dennis R., Guidotti Alessandro The dynamics of DNA methylation in schizophrenia and related psychiatric disorders. Neuropsychopharmacology 2013, 38:138-166.
23. Gu T.P., Guo F., Yang H., Wu H.P., et al. The role of Tet3 DNA dioxygenase in epigenetic reprogramming by oocytes. Nature 2011, 477:606-610.
24. Hackett J.A., Surani M.A. DNA methylation dynamics during the mammalian life cycle. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2013, 368(1609):20110328.
25. He Y.F., Li B.Z., Li Z., Liu P., et al. Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA. Science 2011, 333(6047):1303-1307.
26. Huang N., Tan L., Xue Z., Cang J., et al. Reduction of DNA hydroxymethylation in the mouse kidney insulted by ischemia reperfusion. Biochem. Biophys. Res. Commun. 2012, 422:697-702.
27. Ito S., D'Alessio A.C., Taranova O.V., Hong K., et al. Role of Tet proteins in 5mC to 5-hmC conversion, EScell self-renewal and inner cell mass specification. Nature 2010, 466:1129-1133.
28. Ito S., Shen L., Dai Q., Wu S.C., et al. Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science 2011, 333:1300-1303.
29. Jang H., Shin H., Eichman B.F., Huh J.H., et al. Excision of 5-hydroxymethylcytosine by DEMETER family DNA glycosylases. Biochem. Biophys. Res. Commun. 2014, 446(4):1067-1072.
30. Jones P.A., Baylin S.B. The fundamental role of epigenetic events in cancer. Nat. Rev. Genet. 2002, 3:415-428.
31. Kato T., Iwamoto K. Comprehensive DNA methylation and hydroxymethylation analysis in the human brain and its implication in mental disorders. Neuropharmacology 2014, 80:133-139.
32. Kinney S.M., Chin H.G., Vaisvila R., Bitinaite J., et al. Tissue-specific distribution and dynamic changes of 5-hydroxymethylcytosine in mammalian genomes. J. Biol. Chem. 2011, 286(28):24685-24693.
33. Klose R.J., Yan Q., Tothova Z., Yamane K., et al. The retinoblastoma binding protein RBP2 is an H3K4 demethylase. Cell 2007, 128(5):889-900.
34. Koh K.P., Yabuuchi A., Rao S., Huang Y., et al. Tet1 and Tet2 regulate 5-hydroxymethylcytosine production and cell lineage specification in mouse embryonic stem cells. Cell Stem Cell 2011, 8(2):200-213.
35. Kozaki K., Imoto I., Mogi S., Omura K., et al. Exploration of tumor suppressive microRNAs silenced by DNA hypermethylation in oral cancer. Cancer Res. 2008, 68:2094-2105.
36. Law J.A., Jacobsen S.E. Establishing, maintaining and modifying DNA methylation patterns in plants and animals. Nat. Rev. Genet. 2010, 11:204-220.
37. Li W., Liu M. Distribution of 5-hydroxymethylcytosine in different human tissues. J. Nucleic Acids 2011, 2011:870726.
38. Li D., Zhao Y., Liu C., Chen X., et al. Analysis of MiR-195 and MiR497 expression, regulation and role in breast cancer. Clin. Cancer Res. 2011, 201(17):1722-1730.
39. Liao X.X., Zhan Z.X., Luo Y.Y., Li K., et al. Association study between SNP rs150689919 in the DNA demethylation gene, TET1, and Parkinson's disease in Chinese Han population. BMC Neurol. 2013, 13:196.
40. Liu M., Schatz D.G. Balancing AID and DNA repair during somatic hypermutation. Trends Immunol. 2009, 30:173-181.
41. Lopez-Serra P., Esteller M. DNA methylation-associated silencing of tumor-suppressor microRNAs in cancer. Oncogene 2012, 31:1609-1622.
42. Lu J., Getz G., Miska E.A., Alvarez-Saavedra E., et al. MicroRNA expression profiles classify human cancers. Nature 2005, 435:834-838.
43. Munzel M., Globisch D., Carell T. 5-Hydroxymethylcytosine, the sixth base of the genome. Angew. Chem. Int. Ed. Engl. 2011, 50:6460-6468.
44. Neri F., Krepelova A., Incarnato D., Maldotti M., et al. Dnmt3L antagonizes DNA methylation at bivalent promoters and favors DNA methylation at gene bodies in ESCs. Cell 2013, 155(1):121-134.
45. Neri F., Incarnato D., Krepelova A., Rapelli S., et al. Genome-wide analysis identifies a functional association of Tet1 and Polycomb repressive complex 2 in mouse embryonic stem cells. Genome Biol. 2013, 14(8):R91.
46. Nguyen S., Meletis K., Fu D., Jhaveri S. Ablation of de novo DNA methyltransferase Dnmt3a in the nervous system leads to neuromuscular defects and shortened lifespan. Dev. Dyn. 2007, 236:1663-1676.
47. Olkhov-Mitsel E., Bapat B. Strategies for discovery and validation of methylated and hydroxymethylated DNA biomarkers. Cancer Med. 2012, 1:237-260.
48. Ono R., Taki T., Taketani T., Taniwaki M., et al. LCX, leukemia-associated protein with a CXXC domain, is fused to MLL in acute myeloid leukemia with trilineage dysplasia having t(10;11)(q22;q23). Cancer Res. 2002, 62:4075-4080.
49. Orr B.A., Haffner M.C., Nelson W.G., Yegnasubramanian S., et al. Decreased 5-hydroxymethylcytosine is associated with neural progenitor phenotype in normal brain and shorter survival in malignant glioma. PLoS One 2012, 7:e41036.
50. Panigrahi P.P., Singh T.R. Computational studies on Alzheimer's disease associated pathways and regulatory patterns using microarray gene expression and network data: revealed association with aging and other diseases. J. Theor. Biol. 2013, 334:109-121.
51. Panigrahi G.B., Slean M.M., Simard J.P., Gileadi O., et al. Isolated short CTG/CAG DNA slip-outs are repaired efficiently by hMutSβ, but clustered slip-outs are poorly repaired. PNAS 2010, 107:12593-12598.
52. Pastor W.A., Pape U.J., Huang Y., Henderson H.R., et al. Genome-wide mapping of 5-hydroxymethylcytosine in embryonic stem cells. Nature 2011, 473(7347):394-397.
53. Pfaffeneder T., Hackner B., Truss M., Münzel M., et al. The discovery of 5 formylcytosine in embryonic stem cell DNA. Angew. Chem. Int. Ed. Engl. 2011, 50(31):7008-7012.
54. Pfaffeneder T., Spada F., Wagner M., Brandmayr C., et al. Tet oxidizes thymine to 5-hydroxymethyluracil in mouse embryonic stem cell DNA. Nat. Chem. Biol. 2014, 10(7):574-581.
55. Plongthongkum N., Diep D.H., Zhang K. Advances in the profiling of DNA modifications: cytosine methylation and beyond. Nat. Rev. Genet. 2014, 15(10):647-661.
56. Putiri E.L., Tiedemann R.L., Thompson J.J., Liu C., et al. Distinct and overlapping control of 5-methylcytosine and 5-hydroxymethylcytosine by the TET proteins in human cancer cells. Genome Biol. 2014, 15(6):R81.
57. Schiesser S., Hackner B., Pfaffeneder T., Müller M., et al. Mechanism and stem-cell activity of 5-carboxycytosine decarboxylation determined by isotope tracing. Angew. Chem. Int. Ed. Engl. 2012, 51(26):6516-6520.
58. Schomacher L. Mammalian DNA demethylation: multiple faces and upstream regulation. Epigenetics 2013, 8(7):679-684.
59. Sehgal M., Singh T.R. Identification and analysis of biomarkers for repair proteins: a bioinformatic approach. J. Nat. Sci. Biol. Med. 2012, 3:139-146.
60. Sehgal M., Singh T.R. Systems biology approach for mutational and site-specific structural investigation of DNA repair genes for Xeroderma pigmentosum. Gene 2014, 543:108-117.
61. Sehgal M., Singh T.R. DRGAS: a database of functional genetic variants and their phosphorylation states in human DNA repair systems. DNA Repair (Amst) 2014, 16:97-103.
62. Shen L., Wu H., Diep D., Yamaguchi S., et al. Genome-wide analysis reveals TET- and TDG-dependent 5-methylcytosine oxidation dynamics. Cell 2013, 153(3):692-706.
63. Simon J.A., Kingston R.E. Mechanisms of polycomb gene silencing: knowns and unknowns. Nat. Rev. Mol. Cell Biol. 2009, 10:697-708.
64. Singh T.R., Gupta A., Suravajhala P. Challenges in the miRNA research. Int. J. Bioinform. Res. Appl. 2013, 9:576-583.
65. Song C.X., Szulwach K.E., Fu Y., Dai Q., et al. Selective chemical labeling reveals the genome-wide distribution of 5-hydroxymethylcytosine. Nat. Biotechnol. 2011, 29(1):68-72.
66. Spruijt C.G., Gnerlich F., Smits A.H., Pfaffeneder T., et al. Dynamic readers for 5-(hydroxy)methylcytosine and its oxidized derivatives. Cell 2013, 152(5):1146-1159.
67. Sprujit C.G., Vermeulen Michiel DNA methylation: old dog, new tricks?. Nat. Struct. Mol. Biol. 2014, 21:949-954.
68. Straussman R., Nejman D., Roberts D., Steinfeld I., et al. Developmental programming of CpG island methylation profiles in the human genome. Nat. Struct. Mol. Biol. 2009, 16:564-571.
69. Suzuki H., Maruyama R., Yamamoto E., Kai M., et al. DNA methylation and microRNA dysregulation in cancer. Mol. Oncol. 2012, 6:567-578.
70. Szulwach K.E., Li X., Li Y., Song C.X., et al. Integrating 5-hydroxymethylcytosine into the epigenomic landscape of human embryonic stem cells. PLoS Genet. 2011, 7(6):e1002154.
71. Szwagierczak A., Bultmann S., Schmidt C.S., Spada F., et al. Sensitive enzymatic quantification of 5-hydroxymethylcytosine in genomic DNA. Nucleic Acids Res. 2010, 38(19):e181.
72. Tahiliani M., Koh K.P., Shen Y., Pastor W.A., et al. Conversion of 5-methylcytosine to 5 hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 2009, 324:930-935.
73. Tahiliani M., Koh K.P., Shen Y., Pastor W.A., et al. Conversion of 5 methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 2009, 324(5929):930-935.
74. Tan L., Shi Y.G. Tet family proteins and 5-hydroxymethylcytosine in development and disease. Development 2012, 139(11):1895-1902.
75. Thomson J.P., Hunter J.M., Nestor C.E., Dunican D.S., et al. Comparative analysis of affinity-based 5-hydroxymethylation enrichment techniques. Nucleic Acids Res. 2013, 41(22):e206.
76. Vella P., Scelfo A., Jammula S., Chiacchiera F., et al. Tet proteins connect the O-linked N-acetylglucosamine transferase Ogt to chromatin in embryonic stem cells. Mol. Cell 2013, 49(4):645-656.
77. Violeta P., Arvydas L., Andrew D.P., Fabio M., et al. DNA methylation at the putative promoter region of the human dopamine D2 receptor gene. Neuroreport 1999, 10:1249-1255.
78. Vogelstein B., Papadopoulos N., Velculescu V.E., Zhou S., et al. Cancer genome landscapes. Science 2013, 339(6127):1546-1558.
79. Voigt P., Tee W.W., Reinberg D. A double take on bivalent promoters. Genes Dev. 2013, 27(12):1318-1338.
80. Vrba L., Muñoz-Rodríguez J.L., Stampfer M.R., Futscher B.W., et al. miRNA gene promoters are frequent targets of aberrant DNA methylation in human breast cancer. PLoS One 2013, 8(1):e54398.
81. Wang F., Yang Y., Lin X., Wang J.Q., et al. Genome wide loss of 5-hmC is a novel epigenetic feature of Huntington's disease. Hum. Mol. Genet. 2013, 22:3641-3653.
82. Wanunu M., Cohen-Karni D., Johnson R.R., Fields L., et al. Discrimination of methylcytosine from hydroxymethylcytosine in DNA molecules. J. Am. Chem. Soc. 2011, 133:486-492.
83. Williams K., Christensen J., Pedersen M.T., Johansen J.V., et al. TET1 and hydroxymethylcytosine in transcription and DNA methylation fidelity. Nature 2011, 473:343-348.
84. Wossidlo M., Nakamura T., Lepikhov K., Marques C.J., et al. 5-Hydroxymethylcytosine in the mammalian zygote is linked with epigenetic reprogramming. Nat. Commun. 2011, 2:241.
85. Wu H., Zhang Y. Tet1 and 5-hydroxymethylation: a genome-wide view in mouse embryonic stem cells. Cell Cycle 2011, 10:2428-2436.
86. Wu H., Zhang Y. Mechanisms and functions of Tet protein-mediated 5-methylcytosine oxidation. Genes Dev. 2011, 25:2436-2452.
87. Wu H., D'Alessio A.C., Ito S., Xia K., et al. Dual functions of Tet1 in transcriptional regulation in mouse embryonic stem cells. Nature 2011, 473:389-393.
88. Wu H., D'Alessio A.C., Ito S., Wang Z., et al. Genome-wide analysis of 5-hydroxymethylcytosine distribution reveals its dual function in transcriptional regulation in mouse embryonic stem cells. Genes Dev. 2011, 25:679-684.
89. Xu S., Li W., Zhu J., Wang R., et al. Crystal structures of isoorotate decarboxylases reveal a novel catalytic mechanism of 5-carboxyl-uracil decarboxylation and shed light on the search for DNA decarboxylase. Cell Res. 2013, 23:1296-1309.
90. Yu M., Hon G.C., Szulwach K.E., Song C.X., et al. Tet-assisted bisulfite sequencing of 5-hydroxymethylcytosine. Nat. Protoc. 2012, 7(12):2159-2170.
91. Zhang Z., Jones A., Sun C.W., Li C., et al. PRC2 complexes with JARID2, MTF2, and esPRC2p48 in ES cells to modulate ES cell pluripotency and somatic cell reprogramming. Stem Cells 2011, 29:229-240.
92. Zhang Y., Yan L.-X., Wu Q.-N., Du Z.-M., et al. miR-125b is methylated and functions as a tumor suppressor by regulating the ETS1 proto-oncogene in human invasive breast cancer. Cancer Res. 2011, 71:3552-3562.
93. Zhao H., Chen T. Tet family of 5-methylcytosine dioxygenases in mammalian development. J. Hum. Genet. 2013, 58(7):421-427.
94. Zhubi A., Chen Y., Dong E., Cook E.H., et al. Increased binding of MeCP2 to the GAD1 and RELN promoters may be mediated by an enrichment of 5-hmC in autism spectrum disorder (ASD) cerebellum. Transl. Psychiatry 2014, 4:e349.